Get the Stockscreener App
13.45
4.20%
-0.59
After Hours:
13.47
0.02
+0.15%
Mink Therapeutics Inc stock is traded at $13.45, with a volume of 24,823.
It is down -4.20% in the last 24 hours and down -10.42% over the past month.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
See More
Previous Close:
$14.04
Open:
$14.25
24h Volume:
24,823
Relative Volume:
0.41
Market Cap:
$60.83M
Revenue:
-
Net Income/Loss:
$-24.77M
P/E Ratio:
-18.42
EPS:
-0.73
Net Cash Flow:
$-17.36M
1W Performance:
-7.50%
1M Performance:
-10.42%
6M Performance:
+76.97%
1Y Performance:
+89.70%
1-Day Range:
$13.35
$14.25
1-Week Range:
$13.35
$14.45
52-Week Range:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Name
Mink Therapeutics Inc
Sector
Industry
Phone
212-994-8250
Address
149 FIFTH AVENUE, NEW YORK
Compare INKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
13.45 | 63.50M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Stock (INKT) Latest News
Can trapped investors hope for a rebound in MiNK Therapeutics Inc.Portfolio Update Summary & Community Consensus Trade Alerts - newser.com
How MiNK Therapeutics Inc. (6Q40) stock compares with tech leaders2025 Market Outlook & Weekly Top Gainers Alerts - newser.com
How to monitor MiNK Therapeutics Inc. with trend dashboardsJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Candlestick signals on MiNK Therapeutics Inc. stock todayJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - newser.com
MiNK Therapeutics Inc. recovery potential after sell offQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock inflation resilient2025 Top Decliners & AI Driven Stock Reports - newser.com
Can MiNK Therapeutics Inc. stock resist sector downturnsBull Run & Fast Momentum Entry Tips - newser.com
How resilient is MiNK Therapeutics Inc. stock in market downturnsTrade Analysis Summary & Safe Capital Growth Trade Ideas - newser.com
Can MiNK Therapeutics Inc. recover in the next quarterProduct Launch & Comprehensive Market Scan Reports - newser.com
Will MiNK Therapeutics Inc. stock benefit from sector rotationJuly 2025 Movers & Breakout Confirmation Trade Signals - newser.com
Using fundamentals and technicals on MiNK Therapeutics Inc.2025 Top Decliners & Low Risk Growth Stock Ideas - newser.com
Published on: 2025-11-03 01:49:46 - newser.com
Published on: 2025-11-02 23:27:12 - newser.com
Detecting price anomalies in MiNK Therapeutics Inc. with AIEarnings Miss & Weekly Breakout Stock Alerts - newser.com
Why analysts remain bullish on MiNK Therapeutics Inc. stockTreasury Yields & AI Powered Market Entry Strategies - newser.com
Why MiNK Therapeutics Inc. stock could see breakout soonEarnings Recap Report & Daily Profit Maximizing Tips - newser.com
MiNK Therapeutics Inc. stock outlook for YEARGDP Growth & Stepwise Trade Execution Plans - newser.com
How MiNK Therapeutics Inc. (6Q40) stock moves on employment data2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
Is MiNK Therapeutics Inc. stock safe for conservative investors2025 Earnings Surprises & Capital Efficiency Focused Strategies - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock bottoming after sell offTrade Risk Report & Community Consensus Stock Picks - newser.com
What MACD signals say about MiNK Therapeutics Inc.Quarterly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Published on: 2025-11-02 11:54:11 - newser.com
Published on: 2025-11-02 02:51:55 - newser.com
Published on: 2025-11-02 02:18:51 - newser.com
Earnings visualization tools for MiNK Therapeutics Inc.July 2025 Summary & Trade Opportunity Analysis Reports - newser.com
Published on: 2025-11-01 08:48:26 - newser.com
How to build a custom watchlist for MiNK Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-31 04:18:27 - newser.com
Will MiNK Therapeutics Inc. (6Q40) stock see insider accumulationWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock undervalued historicallyGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Published on: 2025-10-31 01:41:32 - newser.com
What’s next for MiNK Therapeutics Inc. stock priceJuly 2025 Setups & High Conviction Investment Ideas - newser.com
Is MiNK Therapeutics Inc. (6Q40) stock safe for risk averse investorsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Published on: 2025-10-31 00:49:49 - newser.com
Mink Therapeutics Inc Stock (INKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):